Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3331 AL 3345

Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease

Zhang X, Lao K, Qiu Z, Rahman MS, Zhang Y, Gou X.

J Alzheimers Dis. 2019;67(4):1109-1122. doi: 10.3233/JAD-181084.

Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018)

Mishra P, Kumar A, Panda G.

Bioorg Med Chem. 2019 Mar 15;27(6):895-930. doi: 10.1016/j.bmc.2019.01.025. Epub 2019 Jan 25.

γ-Secretase and its modulators: Twenty years and beyond

Xia W.

Neurosci Lett. 2019 May 14;701:162-169. doi: 10.1016/j.neulet.2019.02.011. Epub 2019 Feb 11.

The role of mitochondrial defects and oxidative stress in Alzheimer's disease

Islam BU, Jabir NR, Tabrez S.

J Drug Target. 2019 Nov;27(9):932-942. doi: 10.1080/1061186X.2019.1584808. Epub 2019 Mar 26.

Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?

Franco R, Martínez-Pinilla E, Navarro G.

Expert Opin Drug Discov. 2019 Apr;14(4):327-330. doi: 10.1080/17460441.2019.1581169. Epub 2019 Feb 18.

Potential role of miRNA-140 in Alzheimer's disease

Akhter R, Bekris LM.

Aging (Albany NY). 2019 Feb 19;11(4):1087-1088. doi: 10.18632/aging.101827.

The Effectiveness of Vitamin E Treatment in Alzheimer's Disease

Lloret A, Esteve D, Monllor P, Cervera-Ferri A, Lloret A.

Int J Mol Sci. 2019 Feb 18;20(4):879. doi: 10.3390/ijms20040879.

Comparative Serum Proteomic Analysis of the Effects of Sodium Selenate on a Mouse Model of Alzheimer's Disease

Chen P, Wang LX, Sui XJ, Li SM, Wang Y, Liu Q, Ni JZ.

Biol Trace Elem Res. 2019 Dec;192(2):263-276. doi: 10.1007/s12011-019-01676-9. Epub 2019 Feb 21.

The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications

Arranz AM, De Strooper B.

Lancet Neurol. 2019 Apr;18(4):406-414. doi: 10.1016/S1474-4422(18)30490-3. Epub 2019 Feb 19.

Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease

Li R, Zhang Y, Rasool S, Geetha T, Babu JR.

Oxid Med Cell Longev. 2019 Jan 17;2019:8165707. doi: 10.1155/2019/8165707. eCollection 2019.

Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity

Mullane K, Williams M.

Curr Protoc Pharmacol. 2019 Mar;84(1):e57. doi: 10.1002/cpph.57. Epub 2019 Feb 25.

Low-intensity focused ultrasound for the treatment of brain diseases: safety and feasibility

Toccaceli G, Barbagallo G, Peschillo S.

Theranostics. 2019 Jan 1;9(2):537-539. doi: 10.7150/thno.31765. eCollection 2019.

The emergence of Ephexin5 as a therapeutic target in Alzheimer's disease

Cook EK, Sell GL, Schaffer TB, Margolis SS.

Expert Opin Ther Targets. 2019 Apr;23(4):263-265. doi: 10.1080/14728222.2019.1586884. Epub 2019 Mar 5.

Panax ginseng components and the pathogenesis of Alzheimer's disease (Review)

Razgonova MP, Veselov VV, Zakharenko AM, Golokhvast KS, Nosyrev AE, Cravotto G, Tsatsakis A, Spandidos DA.

Mol Med Rep. 2019 Apr;19(4):2975-2998. doi: 10.3892/mmr.2019.9972. Epub 2019 Feb 19.

Natural barrigenol-like triterpenoids: A comprehensive review of their contributions to medicinal chemistry

Zhang X, Zhang S, Yang Y, Wang D, Gao H.

Phytochemistry. 2019 May;161:41-74. doi: 10.1016/j.phytochem.2019.01.017. Epub 2019 Feb 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias